Employers that move their plan members to ICHRAs (Individual Coverage Health Reimbursement Arrangements) should expect that these individual market plans will not cover GLP-1s for obesity
Limitations And Considerations Key limitations include: Variable shipping and fulfillment timelines Inconsistent customer service experiences Daily order limits, with enrollment reopening at set times Lack of FDA evaluation for compounded medications The service may not be suitable for individuals seeking in-person care, branded FDA-approved medications, or detailed medical reporting
The free program gives patients a science-backed support system designed to address multiple challenges associated with GLP-1s, such as the need to prioritize protein, managing common side effects, and preserving muscle mass while losing weight
Possible Eye Conditions Diabetic retinopathy (DR)
The New England Journal of Medicine , 384(11), 9891002
Simply add to 8-12oz of water, stir thoroughly, and serve over ice